1. X
  2. Structure based drug research @TUDarmstadt
Log inSign up
Structure based drug research @TUDarmstadt
170 posts
Structure based drug research @TUDarmstadt profile banner
user avatar

Structure based drug research @TUDarmstadt

@Hausch_lab
The Hausch Group explores novel therapeutic concepts and innovative approaches to design better pharmacologically active compounds.
Darmstadt, Hessen, Germany
bit.ly/3oQyt3q
Joined February 2021
151
Following
672
Followers
RepliesRepliesMediaMedia
  • user avatar
    Structure based drug research @TUDarmstadt
    @Hausch_lab
    Aug 23, 2024
    For all Macrocycle and Linker afficionados: Check out our perspective recently published in J Med Chem! 📢 The Missing Link(er): A Roadmap to Macrocyclization in Drug Discovery | Journal of Medicinal Chemistry
    Issue Cover
    pubs.acs.org
    The Missing Link(er): A Roadmap to Macrocyclization in Drug Discovery
    Abstract. Macrocycles are one of nature’s preferred choices to generate large but cell-permeable bioactive molecules. Macrocyclization is increasingly prom
  • user avatar
    Structure based drug research @TUDarmstadt
    @Hausch_lab
    Jul 14, 2024
    MC4DD: New EU consortium on drug discovery dedicated to macrocycles. 8 universities and 6 industry partner join forces to advance the science of macrocycles as drugs. More information: MC4DD.com
  • user avatar
    Structure based drug research @TUDarmstadt
    @Hausch_lab
    Jul 11, 2024
    Postdoc in Medicinal Chemistry & Molecular Glue discovery wanted! Combine advanced organic chemistry & cutting edge drug discovery in a vibrant, international team? Further infos: chemie.tu-darmstadt.de/hausch/group_m…
  • user avatar
    Structure based drug research @TUDarmstadt
    @Hausch_lab
    Jun 16, 2024
    Our newest Publikation in ChemMedChem! 1,4‐Pyrazolyl‐containing SAFit‐analogues are selective FKBP51 inhibitors with improved ligand efficiency and drug‐like profile - Buffa - ChemMedChem - Wiley Online Library
    chemistry-europe.onlinelibrary.wiley.com
    1,4‐Pyrazolyl‐Containing SAFit‐Analogues are Selective FKBP51 Inhibitors With Improved Ligand...
    SAFit2 is the current gold standard for the selective inhibition of the FK506-binding protein 51 (FKBP51). While being a useful tool compound, its poor physicochemical profile and large size prevent...
  • user avatar
    Structure based drug research @TUDarmstadt
    @Hausch_lab
    Jun 10, 2024
    Check out our recent publication: Structure‐Based Design of Ultrapotent Tricyclic Ligands for FK506‐Binding proteins - Krajczy - Chemistry – A European Journal - Wiley Online Library …mistry-europe.onlinelibrary.wiley.com/doi/10.1002/ch… Congratulations to Patryk and all who have contributed!
    Structure‐Based Design of Ultrapotent Tricyclic Ligands for FK506‐Binding Proteins
    From chemistry-europe.onlinelibrary.wiley.com

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.